Virometix (private company)
See something wrong or missing? Let us know
Offices:Schlieren
Industry:BiotechHealth services
Business model:B2B
Virometix is a privately held Swiss biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and oncology diseases
values in USD
Investments 23.02M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Virometix
| Name | Criteria | |
|---|---|---|
![]() |
AbolerIS Pharma
42%
|
|
![]() |
Abzena
42%
|
|
![]() |
Acesion Pharma
42%
|
|
![]() |
Achilles Therapeutics
42%
|
|
![]() |
Adrenomed AG
42%
|
|
![]() |
AFYX Therapeutics
42%
|
|
![]() |
Algenex
42%
|
|
![]() |
Alvotech
42%
|
|
![]() |
Antag Therapeutics
42%
|
|
![]() |
Antelope Dx
42%
|
|








Netherlands
Austria
Estonia
Finland
Latvia
Lithuania
Norway
Sweden
Ireland
Italy
Portugal